Unapproved^↗Unapproved and safety records^↗↗

Ipamorelin^↗

Related names in cited records: Ipamorelin acetate^↗

A peptide named in FDA compounding-risk and DOJ enforcement records.^↗↗

Citation markers ↗ open the public records supporting the adjacent statements.

Evidence summary

What the cited records say

FDA's compounding-risk page describes immunogenicity and characterization concerns. A separate Justice Department release names Ipamorelin among unapproved new drugs distributed by the cited pharmacy.^↗↗

This is a source summary, not a medical recommendation. Status may differ by jurisdiction and product.

Cited context

Related records

Organizations named in cited records

U.S. Food and Drug Administration^↗

Dated source history

Updates connected to this profile

No dated update is published for this profile. PeptideScanner does not monitor every source continuously; the current profile summary and cited records remain available below.